Company intelligence / Profile preview
G.CLIPS Biotech
Labège, Occitanie, Francegclips-biotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has developed a platform enabling the generation, profiling, and optimization of therapeutics targeting membrane proteins, supporting monoclonal antibody and immune cell therapy discovery; their pipeline candidate (RCT-001) targeting CXCR2 is in preclinical development for renal cell carcinoma
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Landmark BioVentures (strategic alliance for antibody discovery services)
Beyond the preview
Go deeper on G.CLIPS Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G.CLIPS Biotech.